Document Detail


Therapeutic approach to acute pulmonary embolism.
MedLine Citation:
PMID:  6715683     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Many therapeutic aspects of venous thromboembolism continue to generate controversy so that the general therapeutic guidelines given below are only indicative. The first step is the diagnosis of venous thromboembolism; this is done in the vast majority of patients by visualization of blood clots using either pulmonary angiography or phlebography. The second step is to arrest the thrombotic process; the best means of doing this is to administer IV heparin. In the case of contra-indication or documented inefficacy of heparin therapy, the only therapeutic solution is to interrupt the inferior vena cava either with a clip, an umbrella or a filter. The blood clot lysis, which represents the third step, is effected by the natural fibrinolytic system. Thrombolytics , administered as a bolus of urokinase (15000 CTA U/kg), are indicated in cases of life-threatening pulmonary emboli, i.e. those with a pulmonary vascular obstruction of more than 50% and with hypotension, shock, or acute right ventricular failure. The use of thrombolytics is more questionable when they are administered to improve the quality of vascular patency. The only indication for pulmonary embolectomy is a contra-indication or inefficacy of thrombolytics . Due to the diagnostic and therapeutic difficulties, the first and most important part of the treatment of pulmonary emboli must be the broad application of prophylaxis treatment in patients with a high risk of venous thromboembolism.
Authors:
P Duroux; G Simonneau; P Petitpretz; P Herve
Related Documents :
10386753 - Diagnostic and surgical approach of innominate artery saddle embolus.
2069443 - Intraoperative transesophageal echocardiography for pulmonary embolectomy without cardi...
12136363 - Development of "de novo" aneurysms following endovascular procedures.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Intensive care medicine     Volume:  10     ISSN:  0342-4642     ISO Abbreviation:  Intensive Care Med     Publication Date:  1984  
Date Detail:
Created Date:  1984-06-21     Completed Date:  1984-06-21     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  7704851     Medline TA:  Intensive Care Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  99-102     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Anticoagulants / administration & dosage
Electrocardiography
Fibrinolytic Agents / administration & dosage*
Heparin / administration & dosage
Humans
Pulmonary Embolism / prevention & control,  surgery,  therapy*
Thromboembolism / drug therapy
Urokinase-Type Plasminogen Activator / administration & dosage
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Fibrinolytic Agents; 9005-49-6/Heparin; EC 3.4.21.73/Urokinase-Type Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Circulatory failure in acute pulmonary embolism.
Next Document:  Reading-disabled hyperactive children: a distinct subgroup of attention deficit disorder with hypera...